The BioSpring Advantage
BioSpring, a leading industry expert in nucleic acid science and technology, delivers products at all production scales that meet the highest quality standards for therapeutic and diagnostic applications spanning the complete lifecycle from discovery to commercial use.
Clients can rely on BioSpring’s precision and strict cGMP compliance – guided by our expertise, passion for innovation and more than 25 years of experience.
Our aim is a highly collaborative partnership to unleash the full potential of our clients’ technology – making great strides and breakthroughs possible.
At Any Scale
We support our clients from early small-/mid-scale manufacture of their drug development candidates to late-stage clinical and commercial manufacturing, including all related analytical activities.
- cGMP manufacturing for clinical Phase I – III: Multiple-hundred kg annual capacity
- Process validation and commercial manufacture
- Manufacturing of nucleic acids for R&D, as well as lead candidate screening and development
- Process development – more than 120 successful programs each year
- Scale-up, scale-down and process transfer
- Pre-clinical non-GMP batch manufacture
- Regulatory tox batch manufacture
- Generation of reference standards
